Ved centrale nervesmerter oplevede 21, 7% af de patienter, der var blevet behandlet med Lyrica, en forbedring på mindst 50% i deres smertescore.
In central neuropathic pain, 21.7% of patients treated with Lyrica had a 50% or more improvement in pain score compared to 7.5% of the patients treated with a placebo.